3- 5 years from Killing Cancer
Killing Leukaemia has been the objective of Cancer Research Scientists for decades. Today that objective has come a step closer with the announcement in the international journal, Cancer Research , that TCD in partnership with the University of Sienna have discovered a new drug called PBOX-15 capable of killing cancerous cells in adult patients with poor prognosis.
R&D is still at an early stage however with development of a viable drug between 3- 5 years from being produced according to Professor Mark Lawlor of TCD’S school of medicine. The study itself involved research across the disciplines of molecular, chemistry and biochemistry at TCD together with contributions from Research colleagues in Belfast City Hospital, Siennna and St James Hospital Dublin.
Tags: academic research, Belfast City Hospital, Biochemistry Research, Cancer Research, Drug research, Hospital, Leukaemia, Molecular Biology, R&D, Research and Development, Scientific Research, Scientists, Sienna University, St James Hospital, TCD R&D, Trinity College Dublin, University
